Release Date: 30/07/10 17:20 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 248.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago